Toward a functional future for the cognitive neuroscience of human aging
Neuron,
Journal Year:
2025,
Volume and Issue:
113(1), P. 154 - 183
Published: Jan. 1, 2025
Language: Английский
Transcutaneous Auricular Vagus Nerve Stimulation Does Not Accelerate Fear Extinction: A Randomized, Sham‐Controlled Study
Psychophysiology,
Journal Year:
2025,
Volume and Issue:
62(1)
Published: Jan. 1, 2025
ABSTRACT
Transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
has
been
tested
as
a
strategy
to
facilitate
fear
extinction
learning
based
on
the
hypothesis
that
taVNS
increases
central
noradrenergic
activity.
Four
studies
out
of
six
found
enhance
especially
at
beginning
extinction.
Facilitatory
effects
were
mainly
observed
in
US
expectancy,
less
fear‐potentiated
startle
(FPS),
and
not
skin
conductance
response
(SCR).
Suboptimal
parameters
may
explain
reported
mixed
results.
Also,
variability
selected
conditioning
paradigms
statistical
power
impedes
comparability
between
studies.
This
study
sought
further
test
whether
accelerates
indexed
by
FPS,
SCR.
Similar
most
previous
studies,
we
employed
differential
paradigm.
The
left
ear
79
healthy
participants
was
stimulated
with
either
sham
(earlobe)
or
(cymba
concha)
during
learning.
To
maximize
beneficial
taVNS,
cymba
concha
administered
continuously
maximum
level
below
pain
threshold.
Results
pre‐registered
frequentist
exploratory
Bayesian
analyses
indicate
did
accelerate
any
outcomes.
null
results
commonly
used
does
reliably
optimize
More
research
is
needed
if
protocol
determines
efficacy
optimizing
Language: Английский
Non‐Invasive Auricular Vagus Nerve Stimulation Decreases Heart Rate Variability Independent of Caloric Load
Psychophysiology,
Journal Year:
2025,
Volume and Issue:
62(2)
Published: Feb. 1, 2025
ABSTRACT
The
vagus
nerve
is
crucial
in
regulating
physiological
functions,
including
the
cardiovascular
system.
While
heart
rate
(HR)
and
its
variability
(HRV)
may
provide
non‐invasive
proxies
of
cardiac
vagal
activity,
transcutaneous
auricular
stimulation
(taVNS)
has
yielded
mixed
effects,
with
limited
research
on
right
branch
stimulation.
In
a
randomized
crossover
study
36
healthy
participants,
we
investigated
taVNS
effects
HR
HRV
indexed
by
SDRR,
RMSSD,
HF‐HRV,
LF/HF
ratio.
To
assess
impact
side
(left
vs.
ear)
indices
interaction
state,
recorded
electrocardiograms
four
sessions
per
person,
covering
three
session
phases:
baseline,
during
(taVNS
sham),
post‐milkshake
consumption
First,
found
moderate
evidence
against
affecting
(BF
10
=
0.21).
Second,
decreased
(multivariate
p
0.004)
independent
strong
for
RMSSD
15.11)
HF‐HRV
11.80).
Third,
taVNS‐induced
changes
were
comparable
across
sides
stronger
than
sham,
indicating
consistent
side.
We
conclude
that
reduces
as
SDRR
without
altering
HR,
contradicting
assumption
se
increases
cardiovagal
activity
increased
due
to
stimulating
afferents.
Instead,
our
results
support
role
afferent
activation
arousal.
Crucially,
both
can
safely
modulate
system
increasing
risk
bradycardia
or
causing
adverse
events
offering
new
treatment
possibilities.
Language: Английский